Strength

規格

500mg/5ml

Product   License

PL 43801/0042   - 0001

Indications

適應癥

? on its own   in adults and adolescents from 16 years of age with newly   diagnosed epilepsy, to treat a certain form of epilepsy.

? partial   onset seizures with or without generalisation in adults, adolescents   and children from 4 years of age.

? myoclonic   seizures in adults and adolescents from 12 years of age with juvenile   myoclonic epilepsy.

? primary   generalised tonic-clonic seizures in adults and adolescents from 12 years of age with   idiopathic generalised epilepsy.

?在成人和16歲以下新診斷為癲癇的青少年中單獨治療某種形式的癲癇。

?成人、青少年和4歲以上兒童的部分發作性癲癇，伴有或不伴有全身性發作

?12歲以下患有青少年肌陣攣性癲癇的成人和青少年的肌陣攣性癲癇發作。

?12歲以下患有特發性全身性癲癇的成人和青少年的原發性全身強直陣攣發作。

Approved Date

批準日期

15/02/2017

Market   Authorization Holder

持有人

SCIECURE   PHARMA LIMITED

Manufacture

生產商

Beijing   Sciecure Pharmaceutical Co., Ltd.

北京世橋生物制藥有限公司